Prioritising prevention strategies for patients in antiretroviral treatment programmes in resource-limited settings.
Expanded access to antiretroviral therapy (ART) offers opportunities to strengthen HIV prevention in resource-limited settings. We invited 27 ART programmes from urban settings in Africa, Asia and South America to participate in a survey, with the aim to examine what preventive services had been integrated in ART programmes. Twenty-two programmes participated; eight (36%) from South Africa, two from Brazil, two from Zambia and one each from Argentina, India, Thailand, Botswana, Ivory Coast, Malawi, Morocco, Uganda and Zimbabwe and one occupational programme of a brewery company included five countries (Nigeria, Republic of Congo, Democratic Republic of Congo, Rwanda and Burundi). Twenty-one sites (96%) provided health education and social support, and 18 (82%) provided HIV testing and counselling. All sites encouraged disclosure of HIV infection to spouses and partners, but only 11 (50%) had a protocol for partner notification. Twenty-one sites (96%) supplied male condoms, seven (32%) female condoms and 20 (91%) provided prophylactic ART for the prevention of mother-to child transmission. Seven sites (33%) regularly screened for sexually transmitted infections (STI). Twelve sites (55%) were involved in activities aimed at women or adolescents, and 10 sites (46%) in activities aimed at serodiscordant couples. Stigma and discrimination, gender roles and funding constraints were perceived as the main obstacles to effective prevention in ART programmes. We conclude that preventive services in ART programmes in lower income countries focus on health education and the provision of social support and male condoms. Strategies that might be equally or more important in this setting, including partner notification, prompt diagnosis and treatment of STI and reduction of stigma in the community, have not been implemented widely.
Spaar
A
A
Institute of Social and Preventive Medicine, University of Bern, Switzerland.
Graber
C
C
Dabis
F
F
Coutsoudis
A
A
Bachmann
L
L
McIntyre
J
J
Schechter
M
M
Prozesky
H W
HW
Tuboi
S
S
Dickinson
D
D
Kumarasamy
N
N
Pujdades-Rodriquez
M
M
Sprinz
E
E
Schilthuis
H J
HJ
Cahn
P
P
Low
N
N
Egger
M
M
D000293:Adolescent; D000328:Adult; D000349:Africa; D044966:Anti-Retroviral Agents / Q000627:therapeutic use; D001208:Asia; D002648:Child; D017280:Condoms; D003376:Counseling; D003695:Delivery of Health Care / Q000379:methods / Q000458:organization & administration*; D005260:Female; D015658:HIV Infections / Q000188:drug therapy / Q000517:prevention & control*; D006266:Health Education; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control; D008297:Male; D010353:Patient Education as Topic; D011314:Preventive Health Services / Q000379:methods / Q000458:organization & administration*; D015397:Program Evaluation; D012944:Social Support; D013020:South America; D011795:Surveys and Questionnaires
D044966:Anti-Retroviral Agents
JAMA. 2006 Aug 16;296(7):855-8
16905790
Cochrane Database Syst Rev. 2001;(4):CD002843
11687164
Lancet. 2004 Jul 3-9;364(9428):6-8
15234835
Lancet. 2002 Jun 15;359(9323):2097-104
12086778
Am J Prev Med. 2007 Aug;33(2 Suppl):S89-100
17675019
AIDS. 2005 Apr 29;19(7):699-708
15821396
JAMA. 1992 Dec 16;268(23):3338-43
1453526
Trop Med Int Health. 2008 Jul;13(7):870-9
18373510
Lancet. 2008 May 10;371(9624):1558-9
18468529
Bull World Health Organ. 2008 Dec;86(12):939-47
19142294
Lancet. 2008 Sep 6;372(9641):845-59
18687458
Lancet. 2000 Jun 24;355(9222):2237-44
10881908
Indian J Med Res. 1991 Nov;93:345-9
1797640
AIDS. 1999 Feb 25;13(3):297-306
10199219
Lancet. 2008 May 10;371(9624):1603-11
18468544
Can J Public Health. 1994 Jul-Aug;85 Suppl 1:S41-7
7987758
Bull World Health Organ. 2008 Mar;86(3):210-4
18368208
Am J Prev Med. 2001 Aug;21(2):84-92
11457627
Int J Epidemiol. 2005 Oct;34(5):979-86
16157617
Lancet. 2000 Feb 5;355(9202):451-5
10841125
Health Policy Plan. 2002 Jun;17(2):154-60
12000775
Lancet. 2006 Mar 11;367(9513):817-24
16530575
BMJ. 2007 Feb 17;334(7589):354
17237298
Lancet. 2007 Mar 31;369(9567):1107-16
17398310
AIDS. 2001 May 25;15(8):1045-52
11399987
PLoS Med. 2008 Jul 8;5(7):e148
18613745
Lancet. 2000 Jul 8;356(9224):103-12
10963246
JAMA. 2006 Aug 9;296(6):679-90
16896111